Stanford University
Showing 1-10 of 10 Results
-
Negin Yavari
Visiting Scholar, Ophthalmology Research/Clinical Trials
BioNegin Yavari, MD, is a physician-scientist and Visiting Scholar at the Byers Eye Institute at Stanford University School of Medicine. She received her Doctor of Medicine degree from Tehran Azad University of Medical Sciences in 2017. Her research focuses on advancing diagnostic and therapeutic strategies in ophthalmology, with particular emphasis on ocular inflammatory diseases and retinal vasculitis. Through clinical and translational investigation, including the application of machine learning in ophthalmic imaging, she seeks to improve diagnostic precision, optimize treatment strategies, and reduce the long-term burden of vision loss.
Boards, Advisory Committees & Professional Organizations
•Founding Member, Society for AI in Vision and Ophthalmology (2025–Present)
•Member, Foster Ocular Immunology Society (2025–Present)
•Member, American Academy of Ophthalmology (2023–Present)
•Member, Association for Research in Vision and Ophthalmology (2021–Present) -
Tsai-Chu Yeh, MD, MTM
Postdoctoral Scholar, Ophthalmology
BioDr. Tsai-Chu Yeh is a dedicated vitreoretinal surgeon and scientist. During residency, she was honored with the Best Resident Award, and her research has been featured in Medscape News and the American Academy of Ophthalmology, earning numerous awards from the Association for Research in Vision and Ophthalmology, American Society of Retina Specialists, Fuji Retina, and the Taiwan Retina and Ocular Inflammation Society.
Beyond advancing science, Dr. Yeh is deeply committed to inspiring the next generation by making translational medicine both accessible and impactful. She received the Best Teacher Award for five consecutive years and was promoted to assistant professor as one of the youngest scholars in her field.
Motivated by a passion to bridge science and medicine, she joined the Mahajan Lab at Stanford University as a postdoctoral scholar, where she developed expertise in molecular genetics, honed her passion for discovery, and embraced the lessons of resilience and perseverance. Her research focuses on identifying protein signatures and molecular mechanisms underlying vitreoretinal diseases, aiming to pave the way for targeted, vision-restoring therapies.
Outside the lab and clinic, Dr. Yeh is a true renaissance woman. She finds joy in reading, music and art, and cherishes time with her family and friends. She also enjoys traveling, tennis, and golf. Her vibrant spirit infuses everything she does—bringing energy, empathy, and excellence to her work as a clinician, scientist, and surgeon. -
Charles Yu MD
Assistant Professor of Ophthalmology
Current Research and Scholarly InterestsCorneal opacity is a leading cause of blindness. Cornea transplantation is at high risk of rejection when there is pre-existing vascularization of the cornea and in pediatric patients. Cornea transplant shortage remains a worldwide problem with millions on waitlists. Our laboratory is developing multiple strategies for treatment of corneal blindness. We are testing advanced materials and designs for keratoprostheses with the goal of reducing complications and easing surgical implantation. We are also developing intraocular electronic display prostheses for bypassing cornea opacity, a novel strategy that could allow for high quality vision without corneal clarity.
